RNAimmune is a verifiable biotechnology company and subsidiary of Sirnaomics, specializing in mRNA-based therapeutics and vaccines with approximately $37M in funding (Series A). They have achieved significant regulatory milestones, including FDA IND clearance for Phase I clinical trials of their RSV and COVID-19 booster vaccines. However, the submission's claim that 'most people have used my product' is demonstrably false, as the products are still in early clinical stages with no commercial availability. The project scores high on technical innovation and potential utility but low on current audience reach and response integrity.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline